ADVOCACY

Laboratory-Developed Testing Procedures

AMP's work on LDTs

Laboratory-developed testing procedures are services that hospitals and academic and clinical laboratories develop and use in patient care. These services are not commercially manufactured and marketed but are designed, developed, validated, performed and interpreted by board-certified professionals in a single laboratory.

Learn more


AMP v. FDA lawsuit 

In March 2025, AMP won its lawsuit against the FDA over the agency's final rule on the regulation of LDTs. See our court filings and the judge's decision, which the U.S. government declined to appeal.

Learn more


FDA rule resources for laboratories

In response to the FDA's final rule, AMP created a list of resources for our members and others in the molecular laboratory community. The March 2025 court ruling in AMP's favor vacated the rule.

See the resources

Corporate Partners

  • Merck

    Gold Partner

  • Johnson & Johnson

    Platinum Partner

  • Hologic

    Silver Partner

  • Roche

    Diamond Partner

  • Agena

    Silver Partner

  • AstraZeneca

    Silver Partner

  • Johnson & Johnson

    Platinum Partner

  • Bionano

    Silver Partner

  • Abbvie

    Gold Partner

  • Invivoscribe

    Silver Partner

  • Amgen

    Gold Partner

  • Illumina

    Gold Partner

  • LOXO Oncology

    Gold Partner

  • Bristol-Myers Squibb

    Gold Partner

  • Pfizer

    Gold Partner

  • Asuragen

    Gold Partner

  • Velsera

    Silver Partner

  • ThermoFisher Scientific

    Gold Partner

  • Roche

    Diamond Partner

  • Merck

    Gold Partner

  • Johnson & Johnson

    Platinum Partner

  • Hologic

    Silver Partner

  • Roche

    Diamond Partner

  • Agena

    Silver Partner

  • AstraZeneca

    Silver Partner